EXECUTIVE ENGAGEMENTS
POOL
832
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
166
Interactions with Platform & by Email
PARTICIPANTS
33
Unique # Participated
VALIDATIONS
9
Responses Validated*
COMPANIES
44
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
162
PAGES
236
EDITION
6
PRICE
USD 4950
CODE
MCP14406
*Engagement stats are ongoing and dynamic
Sign-in with email to View Deeper Validated Engagement Details -
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Renal Biomarker estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 5.6% over the analysis period 2020-2027. Functional Biomarker, one of the segments analyzed in the report, is projected to record a 6% CAGR and reach US$923.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Up-Regulated Protein segment is readjusted to a revised 5.2% CAGR for the next 7-year period.
The Renal Biomarker market in the U.S. is estimated at US$321.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$281 Million by the year 2027 trailing a CAGR of 5.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.4% and 4.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.
In the global Other Biomarkers segment, USA, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$91.2 Million in the year 2020 will reach a projected size of US$127.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$183.4 Million by the year 2027.
SELECT PLAYERS
Abbott Molecular, Inc.; Astute Medical, Inc.; Beckman Coulter, Inc.; BioPorto Diagnostics A/S; Randox Laboratories Ltd.; Thermo Fisher Scientific, Inc.
SEGMENTS
» Biomarker (Functional Biomarker, Up-Regulated Protein, Other Biomarkers) » Diagnostic Technique (Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay, Liquid Chromatography-Mass Spectrometry) » End-Use (Diagnostic Labs, Outpatient Clinics, Research Centers, Hospitals)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Renal Biomarker by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Renal Biomarker by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Renal Biomarker by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Functional Biomarker by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Functional Biomarker by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Functional Biomarker by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Up-Regulated Protein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Up-Regulated Protein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Up-Regulated Protein by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Enzyme Linked Immunosorbent Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Enzyme Linked Immunosorbent Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Enzyme Linked Immunosorbent Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Particle-Enhanced Turbidimetric Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Particle-Enhanced Turbidimetric Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Particle-Enhanced Turbidimetric Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Colorimetric Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Colorimetric Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Colorimetric Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Chemiluminescent Enzyme Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Chemiluminescent Enzyme Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Chemiluminescent Enzyme Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Liquid Chromatography-Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Liquid Chromatography-Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Liquid Chromatography-Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Diagnostic Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Outpatient Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Outpatient Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Outpatient Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Renal Biomarker by Biomarker - Percentage Breakdown of Value Sales for Functional Biomarker, Up-Regulated Protein and Other Biomarkers for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Renal Biomarker by Diagnostic Technique - Percentage Breakdown of Value Sales for Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Renal Biomarker by End-Use - Percentage Breakdown of Value Sales for Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Renal Biomarker by Biomarker - Percentage Breakdown of Value Sales for Functional Biomarker, Up-Regulated Protein and Other Biomarkers for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Renal Biomarker by Diagnostic Technique - Percentage Breakdown of Value Sales for Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Renal Biomarker by End-Use - Percentage Breakdown of Value Sales for Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Renal Biomarker by Biomarker - Percentage Breakdown of Value Sales for Functional Biomarker, Up-Regulated Protein and Other Biomarkers for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Renal Biomarker by Diagnostic Technique - Percentage Breakdown of Value Sales for Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Renal Biomarker by End-Use - Percentage Breakdown of Value Sales for Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Renal Biomarker by Biomarker - Percentage Breakdown of Value Sales for Functional Biomarker, Up-Regulated Protein and Other Biomarkers for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Renal Biomarker by Diagnostic Technique - Percentage Breakdown of Value Sales for Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Renal Biomarker by End-Use - Percentage Breakdown of Value Sales for Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Renal Biomarker by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Renal Biomarker by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Renal Biomarker by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Renal Biomarker by Biomarker - Percentage Breakdown of Value Sales for Functional Biomarker, Up-Regulated Protein and Other Biomarkers for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Renal Biomarker by Diagnostic Technique - Percentage Breakdown of Value Sales for Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Renal Biomarker by End-Use - Percentage Breakdown of Value Sales for Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Renal Biomarker by Biomarker - Percentage Breakdown of Value Sales for Functional Biomarker, Up-Regulated Protein and Other Biomarkers for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Renal Biomarker by Diagnostic Technique - Percentage Breakdown of Value Sales for Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Renal Biomarker by End-Use - Percentage Breakdown of Value Sales for Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Renal Biomarker by Biomarker - Percentage Breakdown of Value Sales for Functional Biomarker, Up-Regulated Protein and Other Biomarkers for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Renal Biomarker by Diagnostic Technique - Percentage Breakdown of Value Sales for Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Renal Biomarker by End-Use - Percentage Breakdown of Value Sales for Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Renal Biomarker by Biomarker - Percentage Breakdown of Value Sales for Functional Biomarker, Up-Regulated Protein and Other Biomarkers for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Renal Biomarker by Diagnostic Technique - Percentage Breakdown of Value Sales for Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Renal Biomarker by End-Use - Percentage Breakdown of Value Sales for Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Renal Biomarker by Biomarker - Percentage Breakdown of Value Sales for Functional Biomarker, Up-Regulated Protein and Other Biomarkers for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Renal Biomarker by Diagnostic Technique - Percentage Breakdown of Value Sales for Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Renal Biomarker by End-Use - Percentage Breakdown of Value Sales for Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Renal Biomarker by Biomarker - Percentage Breakdown of Value Sales for Functional Biomarker, Up-Regulated Protein and Other Biomarkers for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Renal Biomarker by Diagnostic Technique - Percentage Breakdown of Value Sales for Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Renal Biomarker by End-Use - Percentage Breakdown of Value Sales for Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Renal Biomarker by Biomarker - Percentage Breakdown of Value Sales for Functional Biomarker, Up-Regulated Protein and Other Biomarkers for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Renal Biomarker by Diagnostic Technique - Percentage Breakdown of Value Sales for Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Renal Biomarker by End-Use - Percentage Breakdown of Value Sales for Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Renal Biomarker by Biomarker - Functional Biomarker, Up-Regulated Protein and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Renal Biomarker by Biomarker - Percentage Breakdown of Value Sales for Functional Biomarker, Up-Regulated Protein and Other Biomarkers for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Renal Biomarker by Diagnostic Technique - Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Renal Biomarker by Diagnostic Technique - Percentage Breakdown of Value Sales for Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay and Liquid Chromatography-Mass Spectrometry for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Renal Biomarker by End-Use - Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Renal Biomarker by End-Use - Percentage Breakdown of Value Sales for Diagnostic Labs, Outpatient Clinics, Research Centers and Hospitals for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 44 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com